Showing 1 - 20 results of 20 for search 'Kuan‐Li Wu', query time: 0.04s
Refine Results
-
1
Cysteinyl Leukotriene Pathway and Cancer by Ming-Ju Tsai, Wei-An Chang, Cheng-Hao Chuang, Kuan-Li Wu, Chih-Hung Cheng, Chau-Chyun Sheu, Ya-Ling Hsu, Jen-Yu Hung
Published 2021-12-01
Article -
2
-
3
-
4
-
5
miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells by Wei-An Chang, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Ya-Ling Hsu
Published 2021-12-01
Article -
6
Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming by Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang, Hung-Hsing Chiang, Lian-Xiu Liu, Ying-Ming Tsai, Jen-Yu Hung
Published 2022-06-01
Article -
7
-
8
Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma by Hsiao-Ling Chen, Yu-Kang Tu, Hsiu-Mei Chang, Tai-Huang Lee, Kuan-Li Wu, Yu-Chen Tsai, Mei-Hsuan Lee, Chih-Jen Yang, Jen-Yu Hung, Inn-Wen Chong
Published 2020-12-01
Article -
9
-
10
Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis by Ying-Ming Tsai, Kuan-Li Wu, Yung-Yun Chang, Wei-An Chang, Yung-Chi Huang, Shu-Fang Jian, Pei-Hsun Tsai, Yi-Shiuan Lin, Inn-Wen Chong, Jen-Yu Hung, Ya-Ling Hsu
Published 2020-07-01
Article -
11
Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer by Ying-Ming Tsai, Kuan-Li Wu, Yung-Yun Chang, Jen-Yu Hung, Wei-An Chang, Chao-Yuan Chang, Shu-Fang Jian, Pei-Hsun Tsai, Yung-Chi Huang, Inn-Wen Chong, Ya-Ling Hsu
Published 2020-02-01
Article -
12
The Downregulation of <i>LSAMP</i> Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis by Chao-Yuan Chang, Kuan-Li Wu, Yung-Yun Chang, Yu-Wei Liu, Yung-Chi Huang, Shu-Fang Jian, Yi-Shiuan Lin, Pei-Hsun Tsai, Jen-Yu Hung, Ying-Ming Tsai, Ya-Ling Hsu
Published 2021-06-01
Article -
13
-
14
Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma by Hsiao-Chen Lee, Chao-Yuan Chang, Yung-Chi Huang, Kuan-Li Wu, Hung-Hsing Chiang, Yung-Yun Chang, Lian-Xiu Liu, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu, Ying-Ming Tsai
Published 2022-05-01
Article -
15
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes by Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yu-Chen Tsai, Cheng-Hao Chuang, Tai-Huang Lee, Huang-Chi Chen, Chih-Jen Yang, Inn-Wen Chong
Published 2022-12-01
Article -
16
Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis by Yu-Chen Tsai, Hsiao-Ling Chen, Tai-Huang Lee, Hsiu-Mei Chang, Kuan-Li Wu, Cheng-Hao Chuang, Yong-Chieh Chang, Yu-Kang Tu, Jen-Yu Hung, Chih-Jen Yang, Inn-Wen Chong
Published 2021-12-01
Article -
17
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR... by Tai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang, Chiou-Mei Wu, Kuan-Li Wu, Chia-Yu Kuo, Po-Ju Wei, Chin-Ling Chen, Hui-Lin Liu, Jen-Yu Hung, Chih-Jen Yang, Inn-Wen Chong
Published 2022-06-01
Article -
18
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis by Kuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, Tai-Huang Lee, Hsiu-Mei Chang, Yu-Chen Tsai, Cheng-Hao Chuang, Yong-Chieh Chang, Yu-Kang Tu, Chih-Jen Yang, Jen-Yu Hung, Inn-Wen Chong
Published 2021-09-01
Article -
19
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with <i>EGFR</i>-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib by Ming-Ju Tsai, Jen-Yu Hung, Juei-Yang Ma, Yu-Chen Tsai, Kuan-Li Wu, Mei-Hsuan Lee, Chia-Yu Kuo, Cheng-Hao Chuang, Tai-Huang Lee, Yen-Lung Lee, Chun-Ming Huang, Mei-Chiou Shen, Chih-Jen Yang, Inn-Wen Chong
Published 2023-03-01
Article -
20
Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer by Cheng-Hao Chuang, Hsiao-Ling Chen, Hsiu-Mei Chang, Yu-Chen Tsai, Kuan-Li Wu, I-Hua Chen, Kung-Chao Chen, Jui-Ying Lee, Yong-Chieh Chang, Chin-Ling Chen, Yu-Kang Tu, Jen-Yu Hung, Chih-Jen Yang, Inn-Wen Chong
Published 2021-04-01
Article